Details of the Drug

General Information of Drug (ID: DMZCDF3)

Drug Name
PAN-301-1
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 1 [1]
Cross-matching ID
TTD ID
D0F7LI

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)